fbpx

Who we are

Pioneers worldwide in the implementation of Personalized Medicine.

International Center for Neurosciences and Genomic Medicine

The EuroEspes International Center for Neurosciences and Genomic Medicine bases its activity on cutting-edge Personalized Medicine using all the diagnostic and therapeutic resources provided by structural and functional genomics, epigenetics, transcriptomics, proteomics and metabolomics.

EuroEspes is an International Reference Center in Genomic Medicine, especially dedicated to diseases of the nervous system and other prevalent diseases (cardiovascular diseases, cancer, metabolic disorders and any genetically based pathology).

The three major pathologies that account for 80% of morbidity and mortality in developed countries are cardiovascular diseases ( 25-35%), cancer (20-30%) and brain disorders (10-20%). Of these prevalent diseases, 80-90% have a multifactorial pathogenesis in which genomic and environmental factors converge. Although these diseases can occur at any age, in more than 70% of cases they are age-dependent pathologies, which accumulate with age, increasing their prevalence in adulthood and old age. Consequently, they are diseases that develop throughout life and, therefore, are predictable with the appropriate predictive procedures, and susceptible to prevention, since when they manifest themselves they have already been undermining our organism for decades.

 

One of the priorities of the International Center for Neurosciences and Genomic Medicine is the implementation of Prevention Plans for prevalent diseases in order to identify them in pre-symptomatic or early stages and to be able to intervene prophylactically on them so that they do not manifest themselves, delay their onset or can be intervened therapeutically in an effective way with personalized protocols of individual pharmacogenetics.

The EuroEspes International Center for Neuroscience and Genomic Medicine is a worldwide pioneer in the implementation of a Personalized Medicine based on knowledge of the Human Genome. EuroEspes makes predictive medicine available to society, which allows it to be one step ahead of prevention and which will become the medicine of the future in the coming years.

We are the first private company dedicated monographically to the research, diagnosis and treatment of diseases of the Central Nervous System. Headquartered in Bergondo (A Coruña), EuroEspes is an international reference and leader in Spain in this field of activity, with pioneering patents in nutraceutical bioproducts and pharmacogenomics.

EuroEspes has been listed on theAlternative EquityMarket(M.A.B. ) since 2011 (currently BME Growth since September 2020).

Our team is made up of healthcare and research personnel with extensive international experience in Japan, the United States, the United Kingdom and India, which, together with state-of-the-art technological equipment, allows us to offer an optimal level in the organization and development of the different medical, healthcare, teaching and research activities. In this way, we have carried out:

  • more than 150 research projects
  • more than 2000 scientific publications

Euroespes Group

The EuroEspes Group, formed by the EuroEspes International Center for Neurosciences and Genomic Medicine, EuroEspes Biotechnology and EuroEspes Publishing, represents an international benchmark in research, implementation and dissemination of the most innovative advances in Genomic and Personalized Medicine, as well as in Health Biotechnology and the development of Therapeutic Bioproducts.

We have more than 30 years of experience in Genomic Medicine and Biotechnology Research.

Recognitions and awards

Euroespes Supplement Award
Euroespes Economic News Award
Pharmacogenetics card economic news award
Cantabrian Euroespes Excellent Cantabrian Award

Leave us your contact information and we will contact you.

Leave us your contact information and we will contact you.